ClinicalTrials.gov
public full text
Public Domain
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
Aim: the aim of this study is to investigated whether the combination of alflutinib with cytotoxic chemotherapy might hold additive efficacy, as well as tolerability .
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy#905308
- Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC#172287
- Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC#640574
- GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line#1161345
- Phase II Trial of Continuation Therapy in Advanced NSCLC#683088
Record · ID 900397
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive